MedTrace Logo

Fractional CO2 Vaginal LASER Therapy for Recurrent Urinary Tract Infection

NCT04301934 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2024-03-26

Study results available
· View outcomes & findings →

Summary

Randomized controlled trial to determine clinical and microbiome difference between fractional CO2 Laser and vaginal estrogen in treating patients with recurrent urinary tract infection (UTI).

Conditions

Interventions

DEVICE

Mona Lisa Touch

Fractional CO2 LASER

DRUG

Conjugated estrogen

Current standard treatment for recurrent UTIs in postmenopausal women

DRUG

Estradiol

Current standard treatment for recurrent UTIs in postmenopausal women

Sponsors & Collaborators

Principal Investigators

  • Johnny Yi, MD · Mayo Clinic

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-06-01
Primary Completion
2023-04-30
Completion
2023-04-30
FDA Device
Yes

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04301934 on ClinicalTrials.gov